Dr. Laskin, who serves as a Distinguished Professor and Chair of the Department of Pharmacology and Toxicology at Rutgers University, has built a career defined by extensive research into pulmonary and hepatic toxicology. Her findings have provided critical insights for developing medical countermeasures against hazardous substances, including mustard agents. With a portfolio exceeding 350 publications, she remains a central figure in shaping modern immunotoxicology.
Debra Laskin named to Forbes 2026 50 Over 50: Innovation list
Over four decades of scientific inquiry into toxicology and pharmacology have earned Dr. Debra L. Laskin a spot on the Forbes 2026 50 Over 50: Innovation list. The honor highlights her pioneering work on how the immune system reacts to chemical threats and the mechanisms driving organ injury.
Beyond her academic output, Laskin serves on the Expert Panel for Fragrance Safety, where she applies her expertise to the independent evaluation of fragrance ingredients. Donald V. Belsito, Chair of the Expert Panel, noted that her intellectual rigor and commitment to mentoring the next generation of scientists have significantly advanced the field. Her role on the panel involves interpreting complex data to ensure human health and environmental protection, a task she balances alongside her academic leadership at the Ernest Mario School of Pharmacy.
Comments (0)
No comments yet. Be the first!